Nanjing, China

Dongyu Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: China Pharmaceutical University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongyu Liu. Retrieved from https://idiyas.com/inventor/dongyu-liu-yp0rso59

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dongyu Liu

Introduction: Dongyu Liu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of immune regulators. His work focuses on innovative compounds that can enhance the body's innate immune response.

Latest Patents: Dongyu Liu holds a patent for a benzo[b]selenophene STING regulator, which includes a preparation method and its various uses. This invention is designed to serve as an immune regulator that effectively activates an innate immune regulation pathway to target and kill tumor cells. The structure of the compound is detailed in Formula I, showcasing its potential in cancer treatment.

Career Highlights: Liu is affiliated with China Pharmaceutical University, where he conducts research and develops new pharmaceutical compounds. His work has garnered attention for its potential applications in immunotherapy and cancer treatment.

Collaborations: Some of his notable coworkers include Zhiyu Li and Jinlei Bian, who contribute to the research and development efforts in his projects.

Conclusion: Dongyu Liu's innovative work in the field of immune regulation highlights the importance of research in developing new therapeutic strategies against cancer. His contributions are paving the way for advancements in pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…